Referências: |
BILODEAU, E.A, COLLINS, B.M. Odontogenic Cysts and Neoplasms. Surg Pathol Clin. v10, n.1, p.177-222, 2017.
CAWSON, R.A.; ODELL, E.W. Cawsons Fundamentos Básicos de Patologia e Medicina Oral. Oitava edição. São Paulo, Guanabara Koogan e Editora Santos, 2013, 477p.
DE BRITO MONTEIRO, B. V. et al. Participation of hMLH1, p63, and MDM2 proteins in the pathogenesis of syndromic and nonsyndromic keratocystic odontogenic tumors. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, v. 120, p. 52-57, 2015.
MORAES, M., et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. Journal of Oral Pathology & Medicine, v. 42, p. 468-473, 2013
EFFIOM, O.A.; OGUNDANA, O.M. AKINSHIPO; A.O, AKINTOYE, S.O. Ameloblastoma: Current Etiopathological Concepts and Management. Oral Dis. 2017
EL-NAGGAR, A.K., CHAN J.K.C., GRANDIS, J.R., TAKATA, T., SLOOTWEG, P.J. WHO Classification of Head and Neck Tumours, 4th Edition, Volume 9, 2017.
WHO Classification of Head and Neck Tumours. WHO/IARC Classification of Tumours, 4th Edition, Volume 9. 2017.
Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017 Mar;11(1):68-77.
|